Found: 28
Select item for more details and to access through your institution.
Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 3, p. 163, doi. 10.1007/s12094-012-0779-1
- By:
- Publication type:
- Article
Clinical approach for managing patients with unexpected CDH1 mutations: A case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
The c.386A>C p.(Asn129Thr) variant in SMAD4 is likely to be pathogenic, causing Juvenile Polyposis Syndrome. A case report of a mosaic variant.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma.
- Published in:
- Journal of Nanobiotechnology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12951-022-01256-5
- By:
- Publication type:
- Article
Frequency and Variability of Genomic Rearrangements on <i>MSH2</i> in Spanish Lynch Syndrome Families.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0072195
- By:
- Publication type:
- Article
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Molecular Divergence upon EGFR -TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR -Sensitizing Mutation.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184446
- By:
- Publication type:
- Article
Functional Signatures in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Sex-Based Differences in Transcriptomic Studies.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 143, doi. 10.3390/cancers13010143
- By:
- Publication type:
- Article
Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.
- Published in:
- European Journal of Human Genetics, 2013, v. 21, n. 8, p. 883, doi. 10.1038/ejhg.2012.268
- By:
- Publication type:
- Article
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1884, doi. 10.1002/1878-0261.13468
- By:
- Publication type:
- Article
Cancer as an infective disease: the role of EVs in tumorigenesis.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 390, doi. 10.1002/1878-0261.13316
- By:
- Publication type:
- Article
NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2363, doi. 10.1002/1878-0261.13033
- By:
- Publication type:
- Article
Comprehensive cross‐platform comparison of methods for non‐invasive EGFR mutation testing: results of the RING observational trial.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 43, doi. 10.1002/1878-0261.12832
- By:
- Publication type:
- Article
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 2, p. 415, doi. 10.1007/s10549-014-3167-4
- By:
- Publication type:
- Article
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 1, p. 273, doi. 10.1007/s10549-011-1909-0
- By:
- Publication type:
- Article
A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 129, n. 3, p. 939, doi. 10.1007/s10549-011-1543-x
- By:
- Publication type:
- Article
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
R-Score: A New Parameter to Assess the Quality of Variants' Calls Assessed by NGS Using Liquid Biopsies.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 10, p. 954, doi. 10.3390/biology10100954
- By:
- Publication type:
- Article
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 14, p. 3666
- By:
- Publication type:
- Article
Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.
- Published in:
- Familial Cancer, 2014, v. 13, n. 1, p. 109, doi. 10.1007/s10689-013-9683-2
- By:
- Publication type:
- Article
Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Capillary Electrophoresis Analysis of Conventional Splicing Assays: IARC Analytical and Clinical Classification of 31 BRCA2 Genetic Variants.
- Published in:
- Human Mutation, 2014, v. 35, n. 1, p. 53, doi. 10.1002/humu.22456
- By:
- Publication type:
- Article
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.943253
- By:
- Publication type:
- Article
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.943253
- By:
- Publication type:
- Article
BRCA1 Alternative splicing landscape in breast tissue samples.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1145-9
- By:
- Publication type:
- Article
BRCA1 Alternative splicing landscape in breast tissue samples.
- Published in:
- 2015
- By:
- Publication type:
- journal article
ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 7, p. 1221, doi. 10.1515/cclm-2020-1465
- By:
- Publication type:
- Article
Next-generation sequencing for tumor mutation quantification using liquid biopsies.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2020, v. 58, n. 2, p. 306, doi. 10.1515/cclm-2019-0745
- By:
- Publication type:
- Article